Trends in Incidence of Intracranial and Spinal Arteriovenous Shunts: Hospital-Based Surveillance in Okayama, Japan.


Journal

Stroke
ISSN: 1524-4628
Titre abrégé: Stroke
Pays: United States
ID NLM: 0235266

Informations de publication

Date de publication:
04 2021
Historique:
pubmed: 19 2 2021
medline: 15 12 2021
entrez: 18 2 2021
Statut: ppublish

Résumé

To date, the incidence of intracranial and spinal arteriovenous shunts has not been thoroughly investigated. We aimed to clarify recent trends in the rates of intracranial and spinal arteriovenous shunts in Japan. We conducted multicenter hospital-based surveillance at 8 core hospitals in Okayama Prefecture between April 1, 2009 and March 31, 2019. Patients who lived in Okayama and were diagnosed with cerebral arteriovenous malformations, dural arteriovenous fistulas (DAVFs), or spinal arteriovenous shunts (SAVSs) were enrolled. The incidence and temporal trends of each disease were calculated. Among a total of 393 cranial and spinal arteriovenous shunts, 201 (51.1%) cases of DAVF, 155 (39.4%) cases of cerebral arteriovenous malformation, and 34 (8.7%) cases of SAVS were identified. The crude incidence rates between 2009 and 2019 were 2.040 per 100 000 person-years for all arteriovenous shunts, 0.805 for cerebral arteriovenous malformation, 1.044 for DAVF, and 0.177 for SAVS. The incidence of all types tended to increase over the decade, with a notable increase in incidence starting in 2012. Even after adjusting for population aging, the incidence of nonaggressive DAVF increased 6.0-fold while that of SAVS increased 4.4-fold from 2010 to 2018. In contrast to previous studies, we found that the incidence of DAVF is higher than that of cerebral arteriovenous malformation. Even after adjusting for population aging, all of the disease types tended to increase in incidence over the last decade, with an especially prominent increase in SAVSs and nonaggressive DAVFs. Various factors including population aging may affect an increase in DAVF and SAVS.

Sections du résumé

BACKGROUND AND PURPOSE
To date, the incidence of intracranial and spinal arteriovenous shunts has not been thoroughly investigated. We aimed to clarify recent trends in the rates of intracranial and spinal arteriovenous shunts in Japan.
METHODS
We conducted multicenter hospital-based surveillance at 8 core hospitals in Okayama Prefecture between April 1, 2009 and March 31, 2019. Patients who lived in Okayama and were diagnosed with cerebral arteriovenous malformations, dural arteriovenous fistulas (DAVFs), or spinal arteriovenous shunts (SAVSs) were enrolled. The incidence and temporal trends of each disease were calculated.
RESULTS
Among a total of 393 cranial and spinal arteriovenous shunts, 201 (51.1%) cases of DAVF, 155 (39.4%) cases of cerebral arteriovenous malformation, and 34 (8.7%) cases of SAVS were identified. The crude incidence rates between 2009 and 2019 were 2.040 per 100 000 person-years for all arteriovenous shunts, 0.805 for cerebral arteriovenous malformation, 1.044 for DAVF, and 0.177 for SAVS. The incidence of all types tended to increase over the decade, with a notable increase in incidence starting in 2012. Even after adjusting for population aging, the incidence of nonaggressive DAVF increased 6.0-fold while that of SAVS increased 4.4-fold from 2010 to 2018.
CONCLUSIONS
In contrast to previous studies, we found that the incidence of DAVF is higher than that of cerebral arteriovenous malformation. Even after adjusting for population aging, all of the disease types tended to increase in incidence over the last decade, with an especially prominent increase in SAVSs and nonaggressive DAVFs. Various factors including population aging may affect an increase in DAVF and SAVS.

Identifiants

pubmed: 33596673
doi: 10.1161/STROKEAHA.120.032052
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1455-1459

Auteurs

Satoshi Murai (S)

Department of Neurological Surgery (S.M., M.H., Y.Y., K.N., Y. Takahashi, J.H., T.H., T.Y., K.S., I.D.), Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Japan.

Masafumi Hiramatsu (M)

Department of Neurological Surgery (S.M., M.H., Y.Y., K.N., Y. Takahashi, J.H., T.H., T.Y., K.S., I.D.), Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Japan.

Etsuji Suzuki (E)

Department of Epidemiology (E.S.), Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Japan.

Ryota Ishibashi (R)

Department of Neurosurgery, Kurashiki Central Hospital, Japan (R.I., M.C.).

Hiroki Takai (H)

Department of Neurosurgery, Kawasaki Medical School, Kurashiki, Japan (H.T., Y.M., S.M., M.U.).

Yuko Miyazaki (Y)

Department of Neurosurgery, Kawasaki Medical School, Kurashiki, Japan (H.T., Y.M., S.M., M.U.).

Yuji Takasugi (Y)

Department of Neurological Surgery (S.M., M.H., Y.Y., K.N., Y. Takahashi, J.H., T.H., T.Y., K.S., I.D.), Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Japan.
Department of Neurosurgery, Okayama City Hospital Okayama City General Medical Center, Japan (Y. Takasugi, K.T.).

Kazuhiko Nishi (K)

Department of Neurological Surgery (S.M., M.H., Y.Y., K.N., Y. Takahashi, J.H., T.H., T.Y., K.S., I.D.), Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Japan.

Yu Takahashi (Y)

Department of Neurological Surgery (S.M., M.H., Y.Y., K.N., Y. Takahashi, J.H., T.H., T.Y., K.S., I.D.), Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Japan.

Jun Haruma (J)

Department of Neurological Surgery (S.M., M.H., Y.Y., K.N., Y. Takahashi, J.H., T.H., T.Y., K.S., I.D.), Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Japan.

Tomohito Hishikawa (T)

Department of Neurological Surgery (S.M., M.H., Y.Y., K.N., Y. Takahashi, J.H., T.H., T.Y., K.S., I.D.), Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Japan.

Takao Yasuhara (T)

Department of Neurological Surgery (S.M., M.H., Y.Y., K.N., Y. Takahashi, J.H., T.H., T.Y., K.S., I.D.), Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Japan.

Masaki Chin (M)

Department of Neurosurgery, Kurashiki Central Hospital, Japan (R.I., M.C.).

Shunji Matsubara (S)

Department of Neurosurgery, Kawasaki Medical School, Kurashiki, Japan (H.T., Y.M., S.M., M.U.).

Masaaki Uno (M)

Department of Neurosurgery, Kawasaki Medical School, Kurashiki, Japan (H.T., Y.M., S.M., M.U.).

Koji Tokunaga (K)

Department of Neurosurgery, Okayama City Hospital Okayama City General Medical Center, Japan (Y. Takasugi, K.T.).

Kenji Sugiu (K)

Department of Neurological Surgery (S.M., M.H., Y.Y., K.N., Y. Takahashi, J.H., T.H., T.Y., K.S., I.D.), Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Japan.

Isao Date (I)

Department of Neurological Surgery (S.M., M.H., Y.Y., K.N., Y. Takahashi, J.H., T.H., T.Y., K.S., I.D.), Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH